|
ⓔPharma Pulse
Volume - 4 | Issue - 178 | 29 March - 4 April 2021
|
|
|
PM reviews COVID-19 Pandemic situation and Vaccination Program in India
|
|
|
Prime Minister Shri Narendra Modi today chaired a high-level meeting to review the COVID-19 Pandemic situation and vaccination program in the country.
The Prime Minister directed that for sustainable COVID-19 management, awareness of the community and its involvement is paramount and there is a need to continue Jan Bhagidari and Jan Andolan for COVID-19 management. Read More
|
|
|
National Policy for Rare Diseases 2021
|
|
|
Dr. Harsh Vardhan, Union Health & Family Welfare Minister approved the “National Policy for Rare Diseases 2021” on 30th March 2021. The policy document has been uploaded on the website of Ministry of Health & Family Welfare. For quite some time different stake holders have been demanding for a comprehensive policy for prevention and management of rare diseases.
The field of rare diseases is very complex and heterogeneous and prevention, treatment and management of rare diseases has multiple challenges. Early diagnosis of rare diseases is a major challenge owing to a variety of factors that include lack of awareness among primary care physicians, lack of adequate screening and diagnostic facilities etc. Read More
|
|
|
Dr. Harsh Vardhan Inaugurates Alignment and Awareness Event for Publicity of DSIR-PRISM Scheme
|
|
|
Union Minister for Science & Technology, Earth Sciences and Health & Family Welfare, Dr Harsh Vardhan toady virtually inaugurated Alignment and Awareness Event for Publicity of the Department of Scientific and Industrial Research - Promoting Innovations in Individuals, Startups and MSMEs (DSIR-PRISM) scheme at IIT Delhi here.
Union Minister of State for Education, Communications, Electronics and Information Technology, Shri Sanjay Dhotre was the Guest of Honour on this occasion. Read More
|
|
|
India’s healthcare industry expected to reach 372 billion dollar in 2022: NITI Aayog
|
|
|
NITI Aayog today released a report outlining the range of investment opportunities in various segments of India’s healthcare sector, including hospitals, medical devices and equipment, health insurance, telemedicine, home healthcare and medical value travel. The report was released by NITI Aayog Member Dr VK Paul, CEO Amitabh Kant, and Additional Secretary Dr Rakesh Sarwal.
India’s healthcare industry has been growing at a Compound Annual Growth Rate of around 22% since 2016. At this rate, it is expected to reach USD 372 billion in 2022. Healthcare has become one of the largest sectors of the Indian economy, in terms of both revenue and employment. Read More
|
|
|
India’s vaccine endeavour truly a ‘Vaccineyaan’: DBT Secretary Renu Swarup
|
|
|
India’s vaccine endeavour in fighting the novel coronavirus can truly be termed ‘vaccineyaan’ because it is going all over the world, said Department of Biotechnology Secretary Renu Swarup.
She said India has had its revolutions in the areas of space and atomic energy where it gained excellence, and similarly its vaccine endeavour is a revolution in the biotechnology sector, she stressed. Read More
|
|
|
India’s Cumulative Vaccination Coverage exceeds 7.3 Crore Doses
|
|
|
In a significant development in the fight against COVID-19, the cumulative number of COVID19 vaccine doses administered in the country has crossed 7.3 Cr mark today.
Cumulatively, 7,30,54,295vaccine doses have been administered through 11,53,614 sessions, as per the provisional report till 7 am today. These include 89,32,642 HCWs (1st dose), 52,96,666 HCWs (2nd dose), 95,71,610 FLWs (1st dose) and 39,92,094 FLWs (2nd Dose) and4,45,77,337 (1st Dose) and 6,83,946 (2nd dose) beneficiaries aged more than 45 years. Read More
|
|
|
COVID-19 mutations foil diagnostic test results, says GlobalData
|
|
|
With hundreds of millions of vaccines being rolled out worldwide, everyone can finally breathe a sigh of relief as the end of the COVID-19 pandemic comes into view. However, more things can still go wrong.
In recent months, several extremely transmissible mutations of the COVID-19 virus have developed, namely the British and South African variants. These viruses have quickly travelled around the world and are in the process of taking over as the cause of most new cases, replacing the original, less transmissible form of COVID-19. Read More
|
|
|
Research reveals how a cell mixes its mitochondria before it divides
|
|
|
In a landmark study, a team led by researchers at the Perelman School of Medicine at the University of Pennsylvania has discovered—and filmed—the molecular details of how a cell, just before it divides in two, shuffles important internal components called mitochondria to distribute them evenly to its two daughter cells.
The finding, published in Nature, is principally a feat of basic cell biology, but this line of research may one day help scientists understand a host of mitochondrial and cell division-related diseases, from cancer to Alzheimer’s and Parkinson’s. Read More
|
|
|
BoA & Director of the Accuprec, Speaker at NSTEB Sponsered and E- Women Entreprenurship Development Program, Supported by Govt of India
|
|
|
On 30th March 2021, NSTEB Sponsered, Organized by Rural Development Foundation, Arihant School of Pharmacy and Bio-Research Institute (ASPBRI), Gandhinagar event on E- Women Entrepreneurship Development Program.
Our Respected Mr. Padmin Buch (Advisor-Corporate Strategy & IPR, Ex-MD - GITCO, BoA of Accuprec) was the Chief Guest at the event. He delivered his knowledge at this Inaugural Function.
|
|
|
|
|